Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and Back to Top removed; overall a minor update with no substantive changes to core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-14T23:48:33.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to include a new version of a publication regarding Lebrikizumab and its effects on inflammatory biomarkers, reflecting a more recent date and revision number.
    Difference
    0.2%
    Check dated 2025-09-07T20:26:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, particularly in South Korea and Poland, as well as a comprehensive list of publications related to the drug lebrikizumab. Additionally, drug safety information and details about skin conditions have been added.
    Difference
    17%
    Check dated 2025-08-31T12:41:17.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T05:13:44.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-10T00:52:32.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.4%
    Check dated 2025-08-02T19:41:38.000Z thumbnail image

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.